• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中风后的痉挛。流行病学与最佳治疗方法。

Spasticity after stroke. Epidemiology and optimal treatment.

作者信息

O'Brien C F, Seeberger L C, Smith D B

机构信息

Movement Disorders Center, Colorado Neurological Institute, Englewood, USA.

出版信息

Drugs Aging. 1996 Nov;9(5):332-40. doi: 10.2165/00002512-199609050-00004.

DOI:10.2165/00002512-199609050-00004
PMID:8922560
Abstract

Spasticity following stroke reflects a spectrum of clinical problems including increased muscle tone, abnormal limb posture, excessive contraction of antagonist muscles and hyperactive cutaneous and tendon reflexes. The prevalence of stroke-related disability in stroke survivors is high, and spasticity may be a significant component of this. Management strategies include a multidisciplinary team approach utilising a variety of rehabilitation techniques. Although some interventions are well tolerated and fairly standardised, older adults may be particularly sensitive to drug treatment-related adverse effects. This article reviews some of the commonly employed interventions, such as oral medications, and some of the newer techniques, such as intrathecal baclofen infusion and botulinum toxin injections. The optimal management of spasticity following stroke in older adults requires careful goal setting and skilful combination of treatment modalities in order to produce the best outcome.

摘要

中风后的痉挛反映了一系列临床问题,包括肌张力增加、肢体姿势异常、拮抗肌过度收缩以及皮肤和腱反射亢进。中风幸存者中与中风相关的残疾患病率很高,而痉挛可能是其中的一个重要因素。管理策略包括采用多学科团队方法并运用多种康复技术。尽管一些干预措施耐受性良好且相当标准化,但老年人可能对药物治疗相关的不良反应特别敏感。本文回顾了一些常用的干预措施,如口服药物,以及一些较新的技术,如鞘内注射巴氯芬和肉毒毒素注射。为了取得最佳效果,对老年人中风后痉挛的最佳管理需要仔细设定目标并巧妙地组合治疗方式。

相似文献

1
Spasticity after stroke. Epidemiology and optimal treatment.中风后的痉挛。流行病学与最佳治疗方法。
Drugs Aging. 1996 Nov;9(5):332-40. doi: 10.2165/00002512-199609050-00004.
2
Management of spasticity in stroke.中风后痉挛的管理
Br Med Bull. 2000;56(2):476-85. doi: 10.1258/0007142001903111.
3
[Treatment of spasticity with botulinum toxin].[肉毒杆菌毒素治疗痉挛]
Rev Neurol (Paris). 1992;148(3):212-4.
4
[Selection of treatment modalities in patients with spasticity].[痉挛患者治疗方式的选择]
Brain Nerve. 2014 Sep;66(9):1031-8.
5
Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial.A型肉毒毒素与短期电刺激治疗脑卒中后上肢屈肌痉挛:一项随机、双盲、安慰剂对照试验
Clin Rehabil. 1998 Oct;12(5):381-8. doi: 10.1191/026921598668275996.
6
[Treatment of spasticity after a stroke].[中风后痉挛的治疗]
Riv Inferm. 1997 Jul-Sep;16(3):167-71.
7
The underutilization of intrathecal baclofen in poststroke spasticity.脊髓内巴氯芬在脑卒中后痉挛中的未充分利用。
Top Stroke Rehabil. 2011 May-Jun;18(3):195-202. doi: 10.1310/tsr1803-195.
8
[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].[肉毒杆菌毒素治疗多发性硬化症患者的髋内收肌痉挛]
Wien Klin Wochenschr. 2001;113 Suppl 4:20-4.
9
Management of spasticity revisited.重新审视痉挛的管理。
Age Ageing. 2013 Jul;42(4):435-41. doi: 10.1093/ageing/aft064.
10
[Clinical treatment (non surgical) of spasticity in cerebral palsy].[脑瘫痉挛的临床治疗(非手术)]
Rev Neurol. 2002;34(1):1-6.

引用本文的文献

1
Cost-Utility Analysis of Incobotulinumtoxin-A Compared With Conventional Therapy in the Management of Post-Stroke Spasticity in Romania.在罗马尼亚,与传统疗法相比,A型肉毒杆菌毒素治疗中风后痉挛的成本-效用分析。
Front Pharmacol. 2020 Jan 16;10:1516. doi: 10.3389/fphar.2019.01516. eCollection 2019.
2
Phase-II Clinical Validation of a Powered Exoskeleton for the Treatment of Elbow Spasticity.用于治疗肘部痉挛的动力外骨骼的二期临床验证
Front Neurosci. 2017 May 12;11:261. doi: 10.3389/fnins.2017.00261. eCollection 2017.

本文引用的文献

1
FUNCTIONAL EVALUATION: THE BARTHEL INDEX.功能评估:巴氏指数
Md State Med J. 1965 Feb;14:61-5.
2
Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.A型肉毒杆菌毒素治疗上肢痉挛:一项随机、双盲、安慰剂对照试验。
Neurology. 1996 May;46(5):1306-10. doi: 10.1212/wnl.46.5.1306.
3
Effect of transdermal clonidine on spinal spasticity. A case series.
Am J Phys Med Rehabil. 1993 Jun;72(3):154-7. doi: 10.1097/00002060-199306000-00009.
4
Intrathecal baclofen for the management of severe spasticity.鞘内注射巴氯芬治疗严重痉挛
N Z Med J. 1993 Apr 14;106(953):129-30.
5
Intrathecal baclofen: does tolerance occur?鞘内注射巴氯芬:会产生耐受性吗?
Paraplegia. 1993 Aug;31(8):516-20. doi: 10.1038/sc.1993.84.
6
Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.量化肉毒杆菌毒素注射的部位和剂量如何影响肌肉麻痹。
Muscle Nerve. 1993 Sep;16(9):964-9. doi: 10.1002/mus.880160913.
7
Mexiletine for treatment of spasticity due to neurological disorders.美西律用于治疗神经系统疾病所致的痉挛。
Muscle Nerve. 1993 Aug;16(8):885.
8
Development of resistance to botulinum toxin type A in patients with torticollis.斜颈患者对A型肉毒杆菌毒素产生耐药性的情况。
Mov Disord. 1994 Mar;9(2):213-7. doi: 10.1002/mds.870090216.
9
Positive response to oral divalproex sodium (Depakote) in patients with spasticity and pain.口服丙戊酸钠(德巴金)对痉挛和疼痛患者有积极疗效。
Am J Med Sci. 1994 Jul;308(1):38-40. doi: 10.1097/00000441-199407000-00009.
10
Correlations between dose, plasma concentrations, and antispastic action of tizanidine (Sirdalud).替扎尼定(妙纳)的剂量、血浆浓度与抗痉挛作用之间的相关性。
J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1355-9. doi: 10.1136/jnnp.57.11.1355.